Promotions & Moves

Synthorx Inc. Appoints New CEO

The new addition is also currently a director of Relay Therapeutics as well as an advisor to the industry

Synthorx Inc. has appointed Laura Shawver, Ph.D., as president, chief executive officer, and director. Dr. Shawver comes with many years of experience as an entrepreneur and drug developer, and has been involved with a number of clinical development programs including two FDA-approved therapies.   “Laura is an accomplished biotech leader, scientist, and drug developer, and we welcome the experience and enthusiasm that she brings to the Synthorx technology and team,” said Jay ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters